- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02835300
Mobile Technology and Online Tools to Improve Asthma Control in Adolescents (CampAirPilot)
June 27, 2017 updated by: 3-C Institute for Social Development
This project will preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control.
In addition to developing a highly novel product for adolescents with asthma, the research proposed for this project will address unique scientific questions.
Despite the high asthma prevalence among adolescents, few interventions have specifically targeted adolescents.
This study is innovative in that it is among the few to focus on adolescents, who are often overlooked by the healthcare system.
This research will assess factors associated with successful implementation of CampAir, thereby providing new information regarding how e-health interventions can be effectively developed and implemented for use with adolescents with asthma.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Asthma has high prevalence and morbidity among adolescents, especially urban Hispanic and African American teenagers.
Despite this, few interventions have specifically targeted adolescents.
School-based and web-based asthma interventions have shown to be effective with younger children, yet few have been developed and tested for adolescents.
Investigators have developed Camp Air, an engaging dynamic e-learning intervention to help adolescents with uncontrolled asthma to manage their illness and to improve their asthma control.
Camp Air consists of seven online modules with one module being completed each week over seven weeks.
Each module provides a brief introduction to the topics and strategies focused on in that module followed by a set of interactive exercises and games for practice and personalized feedback.
The investigators will conduct a two group randomized pilot trial with up to 80, 9th - 12th graders with uncontrolled asthma in order (a) to assess the preliminary intervention effects of Camp Air, and (b) to evaluate the feasibility and acceptability of Camp Air.
In order to evaluate CAMP Air's utility as both a school- and home-based intervention, adolescents will be enrolled from two sites: 1) NYC public schools (n=up to 38), or 2) the national asthma community at large (n=up to 42).
Investigators will also evaluate the reach, acceptability, generalizability, and sustainability of Camp Air using the RE-AIM approach.
Investigators hypothesize that over one month post-intervention, relative to controls, Camp Air participants will show significantly greater improvement in asthma-related outcomes.
Investigators also hypothesize that ratings and software usage indices will demonstrate that Camp Air is a feasible, usable, and acceptable intervention for use with adolescents.
Investigators will also explore evidence of a dose-response in which participants who spend more time engaged with the e-training materials show greater positive change.
Study Type
Interventional
Enrollment (Actual)
79
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27713
- 3-C Institute for Social Development, dba 3C Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 14 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 13 - 18 years
- Prior asthma diagnosis
- Use of a prescribed asthma medication in the past 12 months
- Uncontrolled asthma, defined as (1) daytime symptoms 3+ days per week, (2) night awakenings 1+ nights per week, or (3) 2+ exacerbation events, i.e. 2+ steroid bursts; 2+ emergency department visits, or 1+ hospitalization for asthma.
Exclusion Criteria:
- Co-morbid diseases that affect lung functioning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CampAir Intervention
Adolescents assigned to receive ASMA 2.0 will receive all seven modules over the two month trial, completing one module per week.
Adolescents will be assigned one module per week, but will have free access to all completed modules for the duration of the two-month trial.
Each module is expected to take between 30-40 minutes to complete, although adolescents will be able to engage with the software for as long as desired.
|
CampAir is a dynamic e-learning intervention to help adolescents with uncontrolled asthma to manage their illness and to improve their asthma control.
CampAir consists of seven online modules with one module being completed each week over seven weeks.
Each module provides a brief introduction to the topics and strategies focused on in that module followed by a set of interactive exercises and games for practice and personalized feedback.
|
|
Active Comparator: Information and Referral Control
Adolescents assigned to the information-and-referral control condition will be provided access to existing generic asthma education websites.
They will also be referred to their medical providers for asthma.
After the completion of the trial, all participants will receive access to CampAir.
|
The information and referral comparator condition will provide access to existing generic asthma education websites.
They will also be referred to their medical providers for asthma.
After the completion of the trial, all participants will have access to CampAir.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Night Wakenings Due to Asthma
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up).
|
Adolescent-reported rates of night wakenings due to asthma in the prior 2 weeks.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urgent Health Utilization
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Adolescents will report the number of asthma-related emergency department visits, hospitalizations and acute medical visits in the prior 2 months.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Asthma Morbidity
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Adolescents will report the number of days in the past 2 weeks (1) they experienced symptoms of wheeze, cough, shortness of breath, or chest tightness; (2) they could not carry out normal activities because of asthma; and (3) absences from school due to asthma.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Asthma self-management skills: Attack Management
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Self-management indices for youth used in prior research will be used to assess attack management
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Asthma self-management skills: Symptom Prevention
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Self-management indices for youth used in prior research will be used to assess symptom prevention.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Asthma self-management skills: Asthma Self-Efficacy
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Self-management indices for youth used in prior research will be used to assess asthma self-efficacy.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Quality of life (QOL)
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
QOL in the past week will be assessed with the widely used validated Paediatric Asthma Quality of Life Questionnaire (PAQLQ), which has 23 items in 3 domains: (a) symptoms; (b) emotions, including feelings about self and relationships with siblings or friends; and (c) degree of interference with physical activities.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Asthma control
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Investigators will use Juniper's Asthma Control Questionnaire (ACQ), a 6-item widely used instrument in pediatric research, shown to be sensitive to treatment effects.
Respondents rate their symptoms, night awakening and use of bronchodilators over the previous 7 days on a 7-point scale.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Use of medication
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Adolescents will report the names of their medications, which will be used to determine if oral steroids and controller medications are used; if oral steroids are reported, investigators will also ask how many times they have been used since the last survey to determine the frequency of steroid bursts.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Self-Management subscale of the Asthma Management and Medication Scale (AMMS)
Time Frame: To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
Investigators will use the Self-Management subscale of the Asthma Management and Medication Scale (AMMS), a brief, validated self-report instrument that measures asthma adherence behaviors.
|
To assess change, this measure will be taken: (1) prior to starting the trial (baseline); (2) within two weeks of completing the last module (immediate post-test); and (3) one month after completing their last module (1-month follow-up)
|
|
Intervention feedback
Time Frame: 2 weeks post intervention
|
Adolescents in both conditions will provide feedback regarding their experiences during the trial period.
On a 5-point scale (1=Strongly Disagree to 5=Strongly Agree), respondents will rate the degree to which their experience was: (a) useful for increasing knowledge of asthma and asthma-related symptoms; (b) useful for learning self-management skills; (c) helped decrease the impact of asthma on daily activities; (e) valuable for adolescents with asthma; (f) engaging for adolescents; (g) innovative compared to alternatives; (h) better than alternatives.
Participants will also be asked to provide written comments, listing specific concerns or problems.
Follow-up interviews at school or via telephone by trained research assistants will be conducted to clarify responses and gather additional details, as needed.
|
2 weeks post intervention
|
|
Software usage
Time Frame: Weekly for 7 weeks during intervention
|
The system will collect usage data throughout the trial to document when and how the website and software are being used.
Whenever adolescents access Camp Air, information about that interaction will be captured and time stamped.
Usage statistics will be collected via a combination of HTTP access logs and session cookies to document the number of times a given webpage/tool/resource is accessed, amount of time spent in a given activity, and sequence of steps taken to complete a task.
|
Weekly for 7 weeks during intervention
|
|
After-Scenario Questionnaire (ASQ)
Time Frame: 2 weeks post intervention
|
Adolescents in the intervention condition will evaluate the technology-based product using the After-Scenario Questionnaire (ASQ).
|
2 weeks post intervention
|
|
Post-Study System Usability Questionnaire (PSSUQ)
Time Frame: 2 weeks post intervention
|
Adolescents in the intervention condition will evaluate the technology-based product using the Post-Study System Usability Questionnaire (PSSUQ).
|
2 weeks post intervention
|
|
Technology Acceptance Model (TAM)
Time Frame: 2 weeks post intervention
|
Adolescents in the intervention condition will evaluate the technology-based product using the Technology Acceptance Model (TAM) survey.
|
2 weeks post intervention
|
|
CampAir Evaluation
Time Frame: 2 weeks post intervention
|
Adolescents in the intervention condition will evaluate the technology-based product using a 5-point scale from 1=Not at all to 5=Extremely) the quality of ASMA 2.0 in the following areas: (a) user friendly; (b) easy to navigate; (c) appealing graphic design; (d) easy to follow directions; (e) jargon free; (f) engaging; (g) high quality content; (h) high value content; (i) relevance to real-life; (j) login functions; (k) search functions; and (l) help functions.
|
2 weeks post intervention
|
|
Control Condition Material Usage
Time Frame: 2 weeks post intervention
|
Adolescents assigned to the information-and-referral control condition will answer six questions to assess their use of the educational resources provided to them during the intervention phase.
|
2 weeks post intervention
|
|
Contamination
Time Frame: 2 weeks post intervention
|
Adolescents in the control group in the school sample will be asked three questions about their exposure to CAMP Air, while adolescents in the treatment group in the school sample will be asked questions about their discussing the intervention with other teens in the school and/or sharing the materials with them.
Adolescents in the community sample will not be asked contamination-related questions.
|
2 weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: James Thomas, PhD, 3C Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
May 1, 2017
Study Completion (Actual)
May 1, 2017
Study Registration Dates
First Submitted
June 27, 2016
First Submitted That Met QC Criteria
July 13, 2016
First Posted (Estimate)
July 18, 2016
Study Record Updates
Last Update Posted (Actual)
June 28, 2017
Last Update Submitted That Met QC Criteria
June 27, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R44HL127826 Pilot
- R44HL127826 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Meyer Children's Hospital IRCCSRecruitingAsthma in Children | Asthma Acute | Asthma Crisis | Asthma ChildhoodItaly
-
University of PittsburghNational Institute of Environmental Health Sciences (NIEHS)RecruitingAsthma Exacerbation | Childhood Asthma | Air Pollution, Risk Reduction Behaviors | Asthma ControlUnited States
-
Vanderbilt University Medical CenterWithdrawnAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
Columbia UniversityChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingAcute Asthma | Pediatric Asthma | Non-invasive Positive Pressure Ventilation | BiPAPUnited States
-
SingHealth PolyclinicsRecruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicSingapore
-
Johann Wolfgang Goethe University HospitalCompleted
-
Chiesi Slovenija, d.o.o.RecruitingAsthma | Asthma Bronchiale | Asthma PatientsSlovenia
-
Gümüşhane UniversıtyCompletedAsthma | Asthma Chronic | Asthma ControlTurkey (Türkiye)
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
Clinical Trials on CampAir
-
3-C Institute for Social DevelopmentNew York University; Columbia UniversityCompleted